Nurse tending to a patient

Community Acquired Pneumonia Research Priority Setting Project

We are looking for people who have lived experience of Community Acquired Pneumonia. 

We would like you to join a group of health professionals to help us to see what research would make a difference to adults who have lived experience of community acquired pneumonia.

What is community acquired pneumonia? 

Community acquired pneumonia is the commonest reason that people are admitted to hospital in the UK. It is an infection of one or both lungs that is usually caused by bacteria and viruses. We call it community acquired because people who get it are living in the community as opposed to being in hospital at the time. 

What are we asking you to do? 

We are anticipating that the group will meet monthly for approximately 12 – 18 months. Most of the meetings will be held on-line (virtually) and will take no more than two hours per meeting. 

There may occasionally be face to face meetings which will be a little longer, to make good use of the opportunity to work together in this way. Travel expenses will be reimbursed, and you will also be compensated for your time with non-cash transferable vouchers as a way of saying thank you for your time. 

What do you need to do now? 

Who is funding the project? 

James Lind Alliance and Southmead Hospital Charity 

The James Lind Alliance is non-profit making initiative bringing patients, their families and carers, and clinicians together in a Priority Setting Partnership (PSP) to identify and prioritise uncertainties, or ‘unanswered questions’, about Community Acquired Pneumonia  that have not been answered by previous research, and are important to patients, their families and carers with lived experience, and professionals who look after them. 

Southmead Hospital Charity 

The Charity will be working closely with the Health Professionals and the James Lind Alliance to list  all the possible areas for research will then be discussed and the top 10 prioritised. This will ensure that researchers and those who fund research, focus on what really matters to both patients and clinicians.